Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-23

    Virtual Booth

    An Enquiry

    Menu

    Alisporivir

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Debiopharm begins Phase II trial of alisporivir against Covid-19 in France
    Debiopharm begins Phase II trial of alisporivir against Covid-19 in France

    20 Jan 2021

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/debiopharm-begins-alisporivir-france/

    CLINICALTRIALSARENA
    20 Jan 2021
    Share Share
    Phase II Research Against Covid-19 Launched in France Debiopharm's Alisporivir
    Phase II Research Against Covid-19 Launched in France Debiopharm's Alisporivir

    19 Jan 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/phase-ii-research-against-covid-19-launched-in-france-with-debiopharms-antiviral-alisporivir-301210056.html

    PRNEWSWIRE
    19 Jan 2021
    Share Share
    Phase II Research Against Covid-19 Launched in France Debiopharm's Alisporivir
    Phase II Research Against Covid-19 Launched in France Debiopharm's Alisporivir

    18 Jan 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/phase-ii-research-against-covid-19-launched-in-france-with-debiopharms-antiviral-alisporivir-301210056.html

    PRNEWSWIRE
    18 Jan 2021
    Share Share
    Debiopharm International SA and Solid Biosciences, LLC, Announce a Collaboration to Explore the Use of Alisporivir (Debio 025) in Muscular Dystrophy
    Debiopharm International SA and Solid Biosciences, LLC, Announce a Collaboration to Explore the Use of Alisporivir (Debio 025) in Muscular Dystrophy

    08 Sep 2015

    // PR NEWS WIRE

    http://www.prnewswire.com/news-releases/debiopharm-international-sa-and-solid-biosciences-llc-announce-a-collaboration-to-explore-the-use-of-alisporivir-debio-025-in-muscular-dystrophy-525575061.html

    PR NEWS WIRE
    08 Sep 2015
    Share Share